And Blenrep is now filed with multiple regulators ... And the EMTs are certainly -- they're willing to experiment with this molecule. And we've seen, I mean, we tested it in markets like Italy ...

I just felt I could do so much more. And I really do credit NAD for it.” Camilla Thompson credits the NAD molecule for her improved functioning.Credit: Syl Marie NAD – Nicotinamide adenine ...

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease. Blenrep (belantamab mafodotin) has been ...

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

Blenrep, a treatment for cancer, and asthma medicine Depemokimab are among the planned new launches. Nonetheless, shares in the company fell after it cut its outlook for its annual vaccines sales ...

Back in late 2022, GSK pulled the multiple myeloma ADC Blenrep from the U.S. market merely days after announcing a phase 3 trial flop. The British pharma is now aiming to reintroduce the drug in ...

Blenrep, a treatment for cancer, and asthma medicine Depemokimab are among the planned new launches. Nonetheless, shares in the company fell after it cut its outlook for its annual vaccines sales to a ...

Add a description, image, and links to the molecule-driver topic page so that developers can more easily learn about it.